Altis commissions new Cleanroom facilities at the Innovation Hub in Pretoria South Africa 2013
Altis obtains approval from South African medical aid companies for the reimbursement of ALTIS™ Osteogenic Bone Matrix
Altis wins second-place at the South African Breweries Social Entrepreneurship competition 2013
Altis in negotiations with Brazilian distributor seeking agency for Osteogenic Bone Matrix and DBMX products.
Altis relocates to the Innovation Hub in 2012
2004- Altis Biologics, in consortium with the Tshwane University of Technology ...
The Tshwane University of Technology and Bone SA (organization incorporated not for gain) is awarded a Innovation Fund Grant totalling R14.8 million (2.1 million USD) to develop porcine bone morphogenetic protein complex as a human bone regeneration biomaterial.
Innovation Fund – NRF:
Market Resrach.com – World Study on Regenerative Medicine
International Journal of Biotech:
Certificate of recording of a Pharmacy:
Inspection by SAPC Council:
Licence number GP00099M:
Licence for the Premises:
Registration as a Responsible Pharmacist: